On the heels of $225M roy­al­ty deal, Ko­di­ak shoots for $250M raise to fund piv­otal pro­grams of its Eylea slay­er

Bak­er Bros. didn’t have to wait long for Ko­di­ak Sci­ences’ next stock raise, for which they pledged to in­vest $25 mil­lion. Just a day af­ter nail­ing $225 mil­lion from a sale of fu­ture roy­al­ties to the in­vest­ment firm, Ko­di­ak is of­fer­ing $250 mil­lion worth of shares $KOD on the pub­lic mar­ket.

De­spite a slight drop pre-mar­ket, Ko­di­ak’s cur­rent stock price, at $47, is still up 34% com­pared to Mon­day morn­ing.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN